-
Clin. Pharmacol. Ther. · Aug 2017
ReviewOcclusion in the Flow of New Drugs for Cardiovascular Disease.
- M S Ringel, N A Shah, M Baedeker, C T Lim, A Lamichhane, and U Schulze.
- The Boston Consulting Group, Boston, Massachusetts.
- Clin. Pharmacol. Ther. 2017 Aug 1; 102 (2): 246-253.
AbstractThere is a large misalignment between unmet need and both private and public investment activity in cardiovascular disease. In this paper, we quantify the magnitude of the gap, analyze a range of potential root causes in two main categories (issues of feasibility and valuation), and propose steps toward solutions to close the gap.© 2017 American Society for Clinical Pharmacology and Therapeutics.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.